6-K
Ridgetech Inc. (RDGT)
UNITED STATES****SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATEISSUERPURSUANT TO RULE 13a-16 OR 15d-16 OF THESECURITIES EXCHANGE ACT OF 1934
For the month of January 2022
Commission File Number: 001-40724
CHINAJO-JO DRUGSTORES, INC.
(Translation of registrant’s name into English)
Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District,
Hangzhou City, Zhejiang Province, People’sRepublic of China, 310008(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
China Jo-Jo Drugstores, Inc., a Cayman Islands company (the “Company”) furnishes under the cover of Form 6-K the following:
| Exhibit No. | Description of Exhibit |
|---|---|
| 99.1 | Press Release dated January 26, 2022, announcing it has been granted a second extension to meet the Nasdaq’s minimum bid price requirement. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: January 26, 2022 | CHINA JO-JO DRUGSTORES, INC. | |
|---|---|---|
| By: | /s/ Lei Liu | |
| Name: | Lei Liu | |
| Title: | Chief Executive Officer |
Exhibit 99.1
China Jo-Jo Drugstores Granted Extension to MeetNasdaq Minimum Bid Price Requirement
HANGZHOU, China, January 26, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on January 25, 2022, the Company received another 180 calendar day extension from Nasdaq’s Listing Qualifications Department to meet Nasdaq’s continuing listing requirements by maintaining a minimum bid price per share of $1.00 for a minimum of 10 consecutive trading days. The Company now has until July 25, 2022 to regain compliance.
If at any time before July 25, 2022, the bid price of the Company’s ordinary shares closes at or above $1.00 per share for a minimum of 10 consecutive trading days, the Company will regain compliance with the Nasdaq Listing Rules, and the matter will be closed.
The Company was first notified by Nasdaq of its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A) on July 26, 2021, and was given until January 24, 2022 to regain compliance.
About China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com. The Company routinely posts important information on its website.
Forward-Looking Statements
This press release contains information about theCompany's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materiallyfrom historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but notlimited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business,variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products andservices, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketingand other business development initiatives, competition in the industry, general government regulation, economic conditions, dependenceon key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meetthe requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review other factorsthat may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.
For more information, please contact:
Company Contact:
Frank Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com